Healthcare Frost Radar™: Next-generation Surgical Robotic Technology Platforms, 2021

A Benchmarking System to Spark Companies to Action – Innovation That Fuels New Deal Flow and Growth Pipelines

INDUSTRY
Healthcare

RELEASE DATE
03-Aug-2021
REGION
North America
DELIVERABLE TYPE
Frost Radar

RESEARCH CODE
DA07-01-00-00-00
SKU
HC03436-GL-MR_25622
Yes
SHARE

Frost Radar™: Next-generation Surgical Robotic Technology Platforms, 2021
Published on: 03-Aug-2021 | SKU: HC03436-GL-MR_25622

Need more details?

$4,950.00

$3,712.50 save 25 %

DownloadLink
Need more details?

During the last decade, adoption of robot-assisted surgery has increased significantly as opportunities have multiplied for performing minimally invasive procedures. Overall, surgical robotic platforms facilitate more precise surgeries and improve the repeatability of procedural movements. These benefits support faster recovery and better outcomes for patients. In spite of their many advantages, surgical robotic platforms have drawbacks. Legacy surgical robots involve a large setup that consumes significant space in the operating room. The platforms are not mobile and cannot be transferred from one room to another post installation. Moreover, the instrument setup and positioning of conventional robotic surgical arms before the procedure requires considerable effort, which subsequently increases the total operation time frame.

Next-generation surgical robotic technology platforms have been built with unique designs, advanced instrumentation, and analytics and visualization technologies that address the limitations of conventional surgical robotic systems. These platforms have a smaller footprint that makes them easily accommodated in operating rooms without taking up much space. Moreover, these mobile platforms can be rapidly deployed in various operating rooms to facilitate higher utilization. The unique configuration and minimal cable management of next-generation platforms ensure quick docking and set up that results in shorter operating room time frames for both surgeons and patients. In addition, these platforms complement and extend surgeons’ ability to minimize surgical variability. This is a key factor driving adoption of the platforms among hospitals, as now complex surgical tasks can be performed with greater control and less strain while ensuring patient safety.

In a field of about 30 industry participants, Frost & Sullivan independently plotted in this Frost Radar™ analysis the top 14 companies who are actively involved in developing next-generation surgical robotic technology platforms. The Radar™ reveals the market positioning of each company using its Growth and Innovation scores as highlighted in the Frost Radar™ methodology. The document presents competitive profiles on each company based on its strengths, opportunities, and market positioning. We discuss strategic market imperatives and the competitive environment that vendors operate in as well as make recommendations for each provider to spur growth.

Strategic Imperative

Strategic Imperative (continued)

Strategic Imperative (continued)

Growth Environment

Growth Environment (continued)

Frost Radar™: Next-generation Surgical Robotic Technology Platforms

Frost Radar™

Frost Radar™

Frost Radar™

Intuitive Surgical

CMR Surgical Ltd.

Asensus Surgical, Inc.

Medtronic

Corindus, Inc.

Johnson & Johnson

Robocath, Inc.

Memic Innovative Surgery Ltd.

avateramedical GmbH

Medrobotics Corporation

MicroSure B.V.

Titan Medical Inc.

Virtual Incision Corporation

Preceyes B.V.

Strategic Insights

Significance of Being on the Frost Radar™

Frost Radar™ Empowers the CEO’s Growth Team

Frost Radar™ Empowers Investors

Frost Radar™ Empowers Customers

Frost Radar™ Empowers the Board of Directors

Frost Radar™: Benchmarking Future Growth Potential

Frost Radar™: Benchmarking Future Growth Potential

Legal Disclaimer

Frost Radar™: Benchmarking Future Growth Potential 2 Major Indices, 10 Analytical Ingredients, 1 Platform

Growth Index

Growth Index (GI) is a measure of a company’s growth performance and track record, along with its ability to develop and execute a fully aligned growth strategy and vision; a robust growth pipeline system; and effective market, competitor, and end-user focused sales and marketing strategies.

  • Market Share (previous 3 years)
    This is a comparison of a company’s market share relative to its competitors in a given market space for the previous 3 years.
  • Revenue Growth (previous 3 years)
    This is a look at a company’s revenue growth rate for the previous 3 years in the market/industry/category that forms the context for the given Frost Radar™.
  • Growth Pipeline
    This is an evaluation of the strength and leverage of a company’s growth pipeline system to continuously capture, analyze, and prioritize its universe of growth opportunities.
  • Vision and Strategy
    This is an assessment of how well a company’s growth strategy is aligned with its vision. Are the investments that a company is making in new products and markets consistent with the stated vision?
  • Sales and Marketing
    This is a measure of the effectiveness of a company’s sales and marketing efforts in helping it drive demand and achieve its growth objectives.

Innovation Index

Innovation Index (II) is a measure of a company’s ability to develop products/ services/ solutions (with a clear understanding of disruptive Mega Trends) that are globally applicable, are able to evolve and expand to serve multiple markets and are aligned to customers’ changing needs.

  • INNOVATION SCALABILITY
    This determines whether an organization’s innovations are globally scalable and applicable in both developing and mature markets, and also in adjacent and non-adjacent industry verticals.
  • RESEARCH AND DEVELOPMENT
    This is a measure of the efficacy of a company’s R&D strategy, as determined by the size of its R&D investment and how it feeds the innovation pipeline.
  • PRODUCT PORTFOLIO
    This is a measure of a company’s product portfolio, focusing on the relative contribution of new products to its annual revenue.
  • MEGATRENDS LEVERAGE
    This is an assessment of a company’s proactive leverage of evolving, long-term opportunities and new business models, as the foundation of its innovation pipeline.
  • CUSTOMER ALIGNMENT
    This evaluates the applicability of a company’s products/services/solutions to current and potential customers, as well as how its innovation strategy is influenced by evolving customer needs.

Significance of Being on the Frost Radar™

Companies plotted on the Frost RadarTM are the leaders in the industry for growth, innovation, or both. They are instrumental in advancing the industry into the future.

  • GROWTH POTENTIAL
    Your organization has significant future growth potential, which makes it a Company to Action.
  • BEST PRACTICES
    Your organization is well positioned to shape Growth Pipeline™ best practices in your industry.
  • COMPETITIVE INTENSITY
    Your organization is one of the key drivers of competitive intensity in the growth environment.
  • CUSTOMER VALUE
    Your organization has demonstrated the ability to significantly enhance its customer value proposition.
  • PARTNER POTENTIAL
    Your organization is top of mind for customers, investors, value chain partners, and future talent as a significant value provider.

Have questions about this research or need deeper insights?
Speak directly with our analytics experts for tailored recommendations.

Recent related Healthcare research

15 Sep 2026   |   Global   |   Market Research

Vendor Profiles: Advanced Wound Care Management Market, Global, 2025

The wound care market is being transformed by advanced technologies and evolving care models that focus on improving patient outcomes and reducing healthcare costs. Innovations such as smart sensor-embedded dressings, artificial intelligence (AI)-based wound imaging systems, enhanced negative pressu...

11 Sep 2026   |   Global   |   Frost Radar

Frost Radar™: Pharmaceutical Commercialization Solutions and Services, 2026

Pharmaceutical commercialization is a multidimensional concept in the successful launch and distribution of a drug. The process includes the development of a pricing strategy that reflects the drug’s value, negotiation with payers to ensure drug cost coverage, regulatory compliance, and the generati...

07 Sep 2026   |   Global   |   Technology Research

Synthetic Antibodies and AI-Optimized Immunotherapies

Artificial intelligence is becoming increasingly relevant to antibody discovery and immunotherapy development, supporting target identification, de novo antibody design, antibody engineering, clinical intelligence, and bioprocessing. Advances in generative AI, protein language models, diffusion mode...

28 Aug 2026   |   Global   |   Technology Research

Innovations and Growth Opportunities in Advanced Medical Devices, Artificial Intelligence Solutions, Digital Solutions, and Medical Imaging Solutions

The latest issue of Advanced MedTech Technology Opportunity Engine (TOE) spotlights a diverse slate of innovations across advanced medical devices, artificial intelligence solutions, digital solutions, and medical imaging solutions.The issue features advanced medical devices such as active bioelectr...

27 Aug 2026   |   Global   |   Frost Radar

Frost Radar: AI-Powered Molecular Diagnostics, 2026

AI-powered molecular diagnostics is an emerging and moderately fragmented industry that includes molecular diagnostics companies, precision medicine platforms, sequencing specialists, AI-driven analytics providers, and disease-focused biotechnology companies. No single company has dominated, present...

 

Purchase includes:
  • Report download
  • Growth Dialog™ with our experts

Growth Dialog™

A tailored session with you where we identify the:
  • Strategic Imperatives
  • Growth Opportunities
  • Best Practices
  • Companies to Action

Impacting your company's future growth potential.

During the last decade, adoption of robot-assisted surgery has increased significantly as opportunities have multiplied for performing minimally invasive procedures. Overall, surgical robotic platforms facilitate more precise surgeries and improve the repeatability of procedural movements. These benefits support faster recovery and better outcomes for patients. In spite of their many advantages, surgical robotic platforms have drawbacks. Legacy surgical robots involve a large setup that consumes significant space in the operating room. The platforms are not mobile and cannot be transferred from one room to another post installation. Moreover, the instrument setup and positioning of conventional robotic surgical arms before the procedure requires considerable effort, which subsequently increases the total operation time frame. Next-generation surgical robotic technology platforms have been built with unique designs, advanced instrumentation, and analytics and visualization technologies that address the limitations of conventional surgical robotic systems. These platforms have a smaller footprint that makes them easily accommodated in operating rooms without taking up much space. Moreover, these mobile platforms can be rapidly deployed in various operating rooms to facilitate higher utilization. The unique configuration and minimal cable management of next-generation platforms ensure quick docking and set up that results in shorter operating room time frames for both surgeons and patients. In addition, these platforms complement and extend surgeons ability to minimize surgical variability. This is a key factor driving adoption of the platforms among hospitals, as now complex surgical tasks can be performed with greater control and less strain while ensuring patient safety. In a field of about 30 industry participants, Frost & Sullivan independently plotted in this Frost Radar™ analysis the top 14 companies who are actively involved in developing next-generation surgical robotic technology platforms. The Radar™ reveals the market positioning of each company using its Growth and Innovation scores as highlighted in the Frost Radar™ methodology. The document presents competitive profiles on each company based on its strengths, opportunities, and market positioning. We discuss strategic market imperatives and the competitive environment that vendors operate in as well as make recommendations for each provider to spur growth.
More Information
Deliverable Type Frost Radar
No Index No
Podcast No
Author Neeraj Nitin Jadhav
Industries Healthcare
WIP Number DA07-01-00-00-00
Is Prebook No

Frost Radar™: Next-generation Surgical Robotic Technology Platforms, 2021

$4,950.00

Special Price $3,712.50 save 25 %

In stock
SKU
HC03436-GL-MR_25622